Cargando…

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada

INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Cayley, Pang, Michelle, Nafeh, Frishta, Farrell Macdonald, Shanna, Derkzen, Dena, Rehm, Jürgen, Fischer, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258049/
https://www.ncbi.nlm.nih.gov/pubmed/35787743
http://dx.doi.org/10.1080/17482631.2022.2094111
_version_ 1784741453690306560
author Russell, Cayley
Pang, Michelle
Nafeh, Frishta
Farrell Macdonald, Shanna
Derkzen, Dena
Rehm, Jürgen
Fischer, Benedikt
author_facet Russell, Cayley
Pang, Michelle
Nafeh, Frishta
Farrell Macdonald, Shanna
Derkzen, Dena
Rehm, Jürgen
Fischer, Benedikt
author_sort Russell, Cayley
collection PubMed
description INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada. METHODS: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants’ release. Data were thematically analyzed. RESULTS: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of ‘take-home’ OAT medications were common barriers. CONCLUSIONS: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options.
format Online
Article
Text
id pubmed-9258049
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92580492022-07-07 Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada Russell, Cayley Pang, Michelle Nafeh, Frishta Farrell Macdonald, Shanna Derkzen, Dena Rehm, Jürgen Fischer, Benedikt Int J Qual Stud Health Well-being Article INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada. METHODS: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants’ release. Data were thematically analyzed. RESULTS: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of ‘take-home’ OAT medications were common barriers. CONCLUSIONS: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options. Taylor & Francis 2022-07-05 /pmc/articles/PMC9258049/ /pubmed/35787743 http://dx.doi.org/10.1080/17482631.2022.2094111 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Russell, Cayley
Pang, Michelle
Nafeh, Frishta
Farrell Macdonald, Shanna
Derkzen, Dena
Rehm, Jürgen
Fischer, Benedikt
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title_full Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title_fullStr Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title_full_unstemmed Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title_short Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
title_sort barriers and facilitators to opioid agonist treatment (oat) engagement among individuals released from federal incarceration into the community in ontario, canada
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258049/
https://www.ncbi.nlm.nih.gov/pubmed/35787743
http://dx.doi.org/10.1080/17482631.2022.2094111
work_keys_str_mv AT russellcayley barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT pangmichelle barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT nafehfrishta barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT farrellmacdonaldshanna barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT derkzendena barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT rehmjurgen barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada
AT fischerbenedikt barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada